GNH USA

Europe — EMA

Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

GNH USA supplies Milgamma (Benfotiamine and Pyridoxine Hydrochloride), a vitamin B1 and B6 nutritional supplement for peripheral nerve health and diabetic

Request sourcing

1
Pack/s

What is Benfotiamine, Pyridoxine Hydrochloride?

Benfotiamine and Pyridoxine Hydrochloride, the active ingredient in Milgamma, is a Vitamin B1 (thiamine) derivative and Vitamin B6 presented as a nutritional supplement for oral use. It supports peripheral nerve health, helps manage diabetic neuropathy symptoms, and prevents vitamin B1/B6 deficiency.

GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Benfotiamine, Pyridoxine Hydrochloride used for?

Milgamma, containing benfotiamine and pyridoxine, is used to support peripheral nerve health and carbohydrate metabolism in conditions related to vitamin B1/B6 deficiency.

- Diabetic neuropathy: may alleviate sensory symptoms and improve nerve function. - Vitamin B1 deficiency (beriberi): restores intracellular thiamine phosphate levels. - Vitamin B6 deficiency: supports amino‑acid metabolism and neurotransmitter synthesis.

What are the side effects of Benfotiamine, Pyridoxine Hydrochloride?

Milgamma is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: transient bloating or cramping. - Headache: occasional mild headache. - Skin rash: mild erythema or itching. - Dizziness: brief light‑headedness. - Altered taste: temporary metallic sensation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Stevens‑Johnson syndrome: rare severe skin eruption. - Liver enzyme elevation: abnormal hepatic function tests. - Blood dyscrasias: uncommon changes in blood cell counts. - Pancreatitis: rare inflammation of the pancreas. - Worsening neuropathy: unexpected increase in nerve pain.

What precautions apply to Benfotiamine, Pyridoxine Hydrochloride?

Before initiating Milgamma, consider the following safety measures.

- Assess vitamin status: evaluate baseline B1/B6 levels when possible. - Monitor glucose: observe blood sugar control in diabetic patients. - Renal impairment: adjust use if significant kidney dysfunction is present. - Hypersensitivity: discontinue if any allergic reaction occurs. - Pregnancy/Breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Benfotiamine, Pyridoxine Hydrochloride interact with?

Milgamma may interact with certain medicines; awareness helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Levodopa therapy: pyridoxine can diminish levodopa effectiveness. - High‑dose thiamine supplements: may cause thiamine excess when combined. - Certain chemotherapy agents: concurrent use may mask neuropathy symptoms.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenobarbital): increase vitamin B6 metabolism. - Oral contraceptives: may raise vitamin B6 requirement. - Diuretics: enhance excretion of water‑soluble vitamins. - Alcohol consumption: augments risk of B6 deficiency. - Antacids: can reduce absorption of pyridoxine.

Frequently asked questions

What is Milgamma used for?+
Milgamma is a nutritional supplement that combines benfotiamine (a vitamin B1 derivative) and pyridoxine hydrochloride (vitamin B6). It is used to support peripheral nerve health, help manage symptoms of diabetic neuropathy, and prevent deficiencies of vitamins B1 and B6.
How does benfotiamine work in Milgamma?+
Benfotiamine is a lipid‑soluble pro‑drug of thiamine. After oral absorption, it is converted inside cells to thiamine diphosphate, which participates in carbohydrate metabolism and reduces the formation of harmful advanced glycation end‑products, thereby protecting nerve tissue.
What is the usual dose of Milgamma?+
The appropriate dose of Milgamma is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, renal function, and other factors. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.
Is Milgamma safe during pregnancy or breastfeeding?+
Safety data for Milgamma in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using the product.
How do I order Milgamma from GNH USA?+
To place an order, submit an enquiry on the Milgamma product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Milgamma compare with other vitamin B1/B6 supplements?+
Milgamma combines benfotiamine, a highly bioavailable thiamine pro‑drug, with pyridoxine hydrochloride, offering both enhanced cellular uptake and a broad spectrum of B‑vitamin activity. Compared with standard thiamine or pyridoxine tablets, the benfotiamine component may provide superior support for glucose‑related pathways and nerve protection.
What are the storage requirements for Milgamma?+
Milgamma should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Milgamma administered?+
Milgamma is taken orally, usually with water. The tablet or capsule should be swallowed whole and not chewed or crushed unless directed by a healthcare professional.
What are the most serious risks associated with Milgamma?+
Serious but rare risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant liver enzyme elevations, and blood dyscrasias. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or unexplained fatigue.
Who should not use Milgamma?+
Individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the formulation should avoid Milgamma. Additionally, patients with severe renal impairment or those taking medications that may interact significantly (e.g., levodopa) should consult their physician before use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Benfotiamine, Pyridoxine Hydrochloride
Route
Oral Use
Manufacturer
Wörwag Pharma Gmbh & Co. Kg
Origin
EU

Related products